# Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study)

> **NCT01911078** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 20 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **PROCEDURE:** Renal Denervation
- **DEVICE:** EnligHTN™ Renal Denervation System.

## Key facts

- **NCT ID:** NCT01911078
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-12
- **Final completion:** 2016-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01911078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01911078, "Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01911078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*